Nov 9, 2022· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2022-D-1837-0003
The attached comments are submitted on behalf of the Consumer Healthcare Products Association on November 8, 2022.
FDANonrulemakingFDA-2022-D-1837
Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products
RIN
—
Last modified
Nov 9, 2022
Comment window
closed 1358d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Nov 9, 2022 and Nov 9, 2022. 0 other organizations filed here. The comment window closed 1358d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
Open
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%